Form D · Other Health Care
ECPH, LLC
Dallas, TX · CIK 0001702434
Offering snapshot reported May 14, 2026 · SEC filing
- Reported sold
- $74.6M Indefinite offering
- Investors reported
- 277 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 16, 2022 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$58,565,083 → $74,609,369
- Reported investors190 → 277
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2026 | Amendment | $74,609,369 | $16,044,286vs May 14, 2025 | 277 | SEC filing |
| May 14, 2025 | Amendment | $58,565,083 | $19,150,328vs May 14, 2024 | 190 | SEC filing |
| May 14, 2024 | Amendment | $39,414,755 | $17,887,879vs May 18, 2023 | 127 | SEC filing |
| May 18, 2023 | Amendment | $21,526,876 | $21,121,880vs May 24, 2022 | 66 | SEC filing |
| May 24, 2022 | Initial | $404,996 | No comparison | 2 | SEC filing |
| Aug 13, 2021 | Initial | $250,000 | No comparison | 1 | SEC filing |
| May 21, 2021 | Initial | $115,274,999 | No comparison | Not reported | SEC filing |
| Dec 31, 2020 | Amendment | $9,532,953 | $8,447,953vs Mar 2, 2020 | 31 | SEC filing |
| Jul 9, 2020 | Initial | $12,500,000 | No comparison | 21 | SEC filing |
| Mar 2, 2020 | Amendment | $1,085,000 | $1,085,000vs Feb 28, 2020 | 3 | SEC filing |
| Feb 28, 2020 | Initial | $0 | No comparison | 1 | SEC filing |
| Jul 2, 2019 | Initial | $180,000 | No comparison | 1 | SEC filing |
| Mar 22, 2019 | Initial | $1,469,129 | No comparison | 17 | SEC filing |
| Jan 7, 2019 | Initial | $58,315,569 | No comparison | 25 | SEC filing |
| Apr 6, 2017 | Initial | $29,309,693 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-446769
Source: Form D, filed May 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Anderson | Director, Executive |
| Glenn Askew Iii | Director, Executive |
| James Bradford | Executive |
| Jay Bradford | Director |
| Jeff Browning | Director |
| C. Brett Burford | Executive |
| John K. Carlyle | Director, Executive |
| John Carrig | Director |
| David Carrig | Director |
| Jim Denny | Director |
| Chase Finley | Executive |
| F. Barron Fletcher Iii | Director, Executive |
| F. Barron Fletcher Iii | Director, Executive |
| Jeff S. Fronterhouse | Director, Executive |
| George Gebhardt | Director |
| Charles Matthews | Director, Executive |
| Tracey Mc Carthy | Executive |
| Warren Meyer | Director |
| Richard Parr | Executive |
| John Pitts | Executive |
| Douglas C. Shepard | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
4550 Travis Street Suite 500
Dallas, TX, 75205
Dallas, TX, 75205